Report cover image

Female Sexual Dysfunction Treatment Market Size- By Type, By Indication, By Age- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Publisher SPER Market Research Pvt. Ltd.
Published May 02, 2024
Length 238 Pages
SKU # SPER19034340

Description

Female Sexual Dysfunction Treatment Market Size- By Type, By Indication, By Age- Regional Outlook, Competitive Strategies and Segment Forecast to 2033


Female Sexual Dysfunction Treatment Market Introduction and Overview

According to SPER market research, ‘Female Sexual Dysfunction Treatment Market Size- By Type, By Indication, By Age – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’state that the Female Sexual Dysfunction Treatment Market is predicted to reach USD XX Billion by 2033 with a CAGR of XX%.

Female sexual dysfunction refers to a variety of problems that can have a negative impact on a woman’s quality of life and general well-being. It can cause emotional distress, strained relationships, and decreased self-esteem. Recognising the importance of tackling this issue, the healthcare industry has seen the development of a plethora of treatment options that address various aspects of female sexual dysfunction.

The COVID-19 pandemic has had a mixed influence on the market for treating female sexual dysfunction. While the epidemic initially disrupted healthcare services and reduced patient visits, there has been an increased emphasis on telemedicine and virtual consultations. The epidemic has emphasised the significance of addressing sexual health issues and prompted the development of remote treatment options. However, economic uncertainty and issues with healthcare resource allocation have had an impact on industry growth.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type, By Indication, By Age

Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America

Companies Covered

AMAG Pharmaceuticals Inc., Apricus Biosciences, Inc., Cipla Inc., Duchesnay Inc., Emotional Brain BV, GlaxoSmithKline, Plc, Merck & Co., Inc., Novo Nordisk AS, Pfizer, Inc., Pivot Pharmaceuticals Inc., Sprout Pharmaceuticals, Inc, Others.

Female Sexual Dysfunction Treatment Market Key Segments Covered

By Type:Based on the Type, Global Female Sexual Dysfunction Treatment Market is segmented as; Counselling and Behavioral Therapy, Medication (Hormonal Therapy, Non-Hormonal Therapy), Others.

By Indication:Based on the Indication, Global Female Sexual Dysfunction Treatment Market is segmented as; Arousal Disorder, Female Orgasmic Disorder, Hypoactive Sexual Desire Disorder (HSDD), Penetration (Sexual Pain) Disorder, Others.

By Age: Based on the Age, Global Female Sexual Dysfunction Treatment Market is segmented as; 18-30 Years, 30-45 Years, Above 45 Years.

By Region:This research also includes data for Asia-Pacific, Europe, Middle East and Africa, North America, Latin America.

Table of Contents

238 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Female Sexual Dysfunction Treatment Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Female Sexual Dysfunction Treatment Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Female Sexual Dysfunction Treatment Market
7. Global Female Sexual Dysfunction Treatment Market, By Type (USD Million) 2020-2033
7.1. Global Female Sexual Dysfunction Treatment Market Size, Share and Forecast, By Type, 2020-2026
7.2. Global Female Sexual Dysfunction Treatment Market Size, Share and Forecast, By Type, 2027-2033
7.3. Counselling and Behavioral Therapy
7.4. Medication
7.4.1. Hormonal Therapy
7.4.2. Non-Hormonal Therapy
7.5. Others
8. Global Female Sexual Dysfunction Treatment Market, By Indication (USD Million) 2020-2033
8.1. Global Female Sexual Dysfunction Treatment Market Size, Share and Forecast, By Indication, 2020-2026
8.2. Global Female Sexual Dysfunction Treatment Market Size, Share and Forecast, By Indication, 2027-2033
8.3. Arousal Disorder
8.4. Female Orgasmic Disorder
8.5. Hypoactive Sexual Desire Disorder (HSDD)
8.6. Penetration (Sexual Pain) Disorder
8.7. Others
9. Global Female Sexual Dysfunction Treatment Market, By Age (USD Million) 2020-2033
9.1. Global Female Sexual Dysfunction Treatment Market Size, Share and Forecast, By Age, 2020-2026
9.2. Global Female Sexual Dysfunction Treatment Market Size, Share and Forecast, By Age, 2027-2033
9.3. 18-30 Years
9.4. 30-45 Years
9.5. Above 45 Years
10. Global Female Sexual Dysfunction Treatment Market Forecast, 2020-2033 (USD Million)
10.1. Global Female Sexual Dysfunction Treatment Market Size and Market Share
11. Global Female Sexual Dysfunction Treatment Market, By Region, 2020-2033 (USD Million)
11.1. Global Female Sexual Dysfunction Treatment Market Size and Market Share By Region (2020-2026)
11.2. Global Female Sexual Dysfunction Treatment Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle East & Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. AMAG Pharmaceuticals Inc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Apricus Biosciences, Inc
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Cipla Inc
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Duchesnay Inc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Emotional Brain BV
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. GlaxoSmithKline, Plc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Merck & Co., Inc
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Novo Nordisk AS
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Pfizer, Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Pivot Pharmaceuticals Inc
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Sprout Pharmaceuticals, Inc.
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Others
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us